
Georgia Davis
Contributor at Women's Health
Present: @TeachForAmerica | Bylines: @womenshealthmag | Past: @ThePost OU @FirstReelPod @glaad | Put me on Survivor | 💗💜💙 she/her
Articles
-
2 months ago |
jamanetwork.com | Francisco J Pasquel |Georgia Davis |David Huffman |Anne Peters
Key PointsQuestion Is automated insulin delivery (AID) safe and effective for use in adults with type 2 diabetes who are being treated with insulin with or without other glucose-lowering medications? Findings In this nonrandomized clinical trial including 305 adults with type 2 diabetes, there was a significant decrease in hemoglobin A1c (HbA1c) levels from 8.2% to 7.4% after 13 weeks of AID use, representing a 0.8–percentage point reduction.
-
Oct 23, 2024 |
jamanetwork.com | Piaopiao Li |Elizabeth Staton |Georgia Davis |Hui Shao
Two newer glucose-lowering medications, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors, have significant cardiorenal benefits and advantages in weight management.1 These medications are not approved for type 1 diabetes (T1D), but some evidence indicates their use in this population.2 This study explored prescribing trends for individuals with T1D prescribed GLP-1RAs and SGLT2 inhibitors.
-
Oct 9, 2024 |
dom-pubs.onlinelibrary.wiley.com | Georgia Davis |Anne Peters |Bruce Bode |Anders Carlson
1 INTRODUCTION Comprehensive management of type 2 diabetes (T2D) requires a multifaceted approach to achieve care goals surrounding blood pressure, lipids and glucose targets to reduce the risks of micro- and macrovascular complications.1 The use of glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium glucose cotransporter-2 inhibitors (SGLT-2i) with their associated cardiorenal benefits highlights how advances in glucose-lowering therapy can change the paradigm for pharmacologic...
-
Sep 27, 2024 |
aol.com | Georgia Davis |Lily Wohlner
September 27, 2024 at 3:06 PMYour Bunion Won't Hate Any Of These ShoesHearst Owned"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." If you have bunions—a joint deformity caused by the internal shift of the big toe joint—you know it can be difficult to find comfortable walking shoes, not to mention stylish heels, hiking shoes, and the list goes on. But don't underestimate the importance of providing your little piggies with a proper home.
-
Aug 23, 2024 |
lexology.com | Georgia Davis |Noonie Holmes
In AGA Rangemaster Group v UK Innovations Group, [2024] EWHC 1727 (IPEC), AGA Rangemaster UK Ltd (AGA), brought a successful claim against UK Innovations Group Ltd (UK Innovations) and its director Michael McGinley for trade mark infringement in relation to their marketing and sales of AGA cookers that had been "retrofitted" with electrifying control panels, using UK Innovations' specialised "eControl System".
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 558
- Tweets
- 8K
- DMs Open
- Yes

This Cirie superhero montage is so good #bb25

So nice to see Cormerica wore black to their funeral #bb25

That moment between Matt and Jag in last night’s episode 🥹 #bb25